Christopher Kelly

Urologist at NYU Langone Health;
Director of Benign Prostatic Disease; Faculty member
Department of Urology

[Perlmutter Cancer Center at NYU Langone Health @Perlmutter_CC]

Join us @NYULangoneLI for a FREE #MensHealthMonth community event, including expert talks on prostate & colorectal cancer, heart & bone health, sleep, fertility, weight loss & more. RSVP: https://t.co/ucPWTQfspm

@drsherv @_ChrisKelly @UroOncologist @RadioDoctorKatz @valaryraup

[Christopher Kelly @_ChrisKelly]

@dcwolfmoon @___TheGOOdWitch Completely. She was not truly listening. She was just waiting for him to stop speaking so she could say what she wanted to say. Not truly being present. And her saccharine smile and condescension were insufferable.

[Christopher Kelly @_ChrisKelly]

@thesigmamindset Routine

[Christopher Kelly @_ChrisKelly]

@JuniorLozano_ Hi

[Christopher Kelly @_ChrisKelly]

@PROCEPTRobotics Congratulations to all!

[PROCEPT BioRobotics @PROCEPTRobotics]

Thank you, #KevinZorn, #DavidCuellar, #BrianHelfand, #ChristopherKelly, #RaviMunver, MD for sharing your invaluable insights on Aquablation® therapy with surgeons nationwide! We are thrilled to have hosted the first PROCEPT BioRobotics® Prostate Innovation Forum in Chicago, where we explored multiple topics in prostate health and why Aquablation therapy is setting a new standard of care for BPH.

“We all benefit when we learn from each other. It is a privilege to share the value many of us find with Aquablation® therapy – the ability to provide a predictable, reproducible, and scalable procedure for an ever-growing BPH patient population.” Kevin Zorn, MD

#AquablationTherapy #BPH

[PROCEPT BioRobotics @PROCEPTRobotics]

NASDAQ welcomed PROCEPT BioRobotics® back to New York City to celebrate being one of the world’s fastest-growing surgical robotics companies! We're thrilled to see Aquablation® therapy rapidly becoming the standard of care for BPH, and revolutionizing treatment for patients.

🚀 Q3 2024 Highlights for PROCEPT BioRobotics 🚀

It’s been an exciting quarter as we continue to advance in the field of BPH treatment! Here are some standout achievements from Q3:

• Strong momentum accelerating adoption, reflected in our Q3 earnings
• Launch of the HYDROS™ Robotic System, the next generation surgical platform
• Celebrated 3-year IPO anniversary
• Aggregate gross proceeds of approximately $175 million in capital to fuel strategic growth

Here’s to more milestones and making a meaningful impact in the urology space!

#PROCEPTBioRobotics #NASDAQ #Aquablation #BPH #SurgicalInnovation #Movember

https://t.co/f14NWNwqV0

[Hossein Sadeghi-Nejad @Hossein5555]

Fantastic first two presentations inaugurating @NYSAUA Marrakesh by our very own @NYUUrology Drs. James Wysock on the ExoDx test for high grade prostate cancer risk assessment and Katie Murray on non muscle invasive bladder cancer.

[NYU Langone Urology @NYUUrology]

Great presentation by Dr @_ChrisKelly about Aquablation at @NYSAUA annual meeting in Marrakesh

[Christopher Kelly @_ChrisKelly]

@PROCEPTRobotics Congratulations Doc!

[Christopher Kelly @_ChrisKelly]

Join me at the Procept BioRobotics Hands-On Workshops! It's a fantastic chance for surgeons interested in #Aquablationtherapy to get hands-on experience with the robotic system and engage with peers like me who actively perform Aquablation therapy.

[Christopher Kelly @_ChrisKelly]

@PROCEPTRobotics Congratulations to all!

[PROCEPT BioRobotics @PROCEPTRobotics]

Did you know that Procept BioRobotics is conducting clinical research with Aquablation Therapy in men with localized prostate cancer (grade group 1 or 2). If you live in the New York, Chicago, or Los Angeles area, please contact one of our participating centers. The use of product in this clinical study is limited by United States law to investigational use.
For more information about the study please click the link below. https://t.co/43XDTT2U2M

[KATIE MURRAY @KSMurrayUro]

Announcement to the future urologists out there. Check out ✅ this rare opportunity to join @NYUUrology @NYUUROresidency for learning, operating, and making colleagues in a great location. @AmerUrological @UroAcademic 🗽💫😷

[NYU Grossman School of Medicine @nyugrossman]

A clinical trial led by researchers at @Perlmutter_CC is studying the efficacy of aquablation therapy as a treatment option for patients with an enlarged prostate and localized prostate cancer.

Learn more: https://t.co/6D8uzMZrAk

[Perlmutter Cancer Center at NYU Langone Health @Perlmutter_CC]

An innovative multi-center study, led by our urologic oncologist Dr. Hebert Lepor of @NYUUrology, is studying the efficacy of #aquablation focal therapy in localized #prostatecancer.

Learn about this minimally invasive treatment approach: https://t.co/qF8eE1Mb7f

[Aquablation Therapy @myaquablation]

Time for a crash course in Anatomy 101! Dr. Kelly's stepping up to decode the mystery behind prostates.

Curious about BPH? Discover what it is and how to tackle it head-on: https://t.co/y8qytH82XA “Not all patients will experience the same results.” #ProstateHealthMonth

[KATIE MURRAY @KSMurrayUro]

This was such a fun session to be a part of. Learning from the best of the best @FaltasLab @SurenaMatinMD @HougenHY @Dr_Jen_Linehan @JCensits. Also look at all those #WUO members on the podium! Thx @UroOnc for recognizing and being inclusive.

[Stacy Loeb, MD @LoebStacy]

Provocative study of radical prostatectomy without prior biopsy for patients w/ PSA>10 + high suspicion MRI/PSMA PET. All patients had clinically significant #prostatecancer on final pathology. No data yet if avoiding biopsy impacts functional outcomes -Stief #aaeu23

[KATIE MURRAY @KSMurrayUro]

Fun crew to support the @NYSAUA and @DrLaMontBarlow @NYUUrology. Great event raising awareness for Young Urologists!